TerminatedNCT00182533
Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
Medication studyAges 18–70Canada
Understand this study
Who could participate?
Listed age limits: 18 years to 70 years.
What will I do during this study?
Depending on the group, the protocol specifies the study medication (sertraline) or a placebo (an inactive comparison treatment).
- Listed locations
- HamiltonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJuly 2002
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 170
- Sponsor
- Hamilton Health Sciences Corporation
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT00182533
- Official title
Show the full official title
Sertraline in the Treatment of Generalized Social Phobia With Comorbidity
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Hamilton
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Hamilton Health Sciences Corporation.
Does this study involve medication?
Yes. The study involves medication, including Sertraline and Placebo.
Who can participate?
Listed age limits: 18 years to 70 years.
Is this study still recruiting?
The registry lists this study as terminated.
